Navigation Links
Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
Date:4/12/2011

SUNNYVALE, Calif., April 12, 2011 /PRNewswire/ -- Asante Solutions, Inc. (Asante), a medical device company focused on diabetes care, today announced it received the CE mark for its Pearl Insulin Pump, the only insulin pump that uses a pre-filled insulin cartridge. The CE mark is a European proof of conformity that certifies the product meets EU safety, health and environmental requirements. Asante has begun discussions with potential distribution partners in Europe.

"This important regulatory milestone brings us one step closer to our goal of delivering a sensible solution to the growing but underserved insulin pump market," said Phil Hopper, Asante CEO and President. "Once available, we believe the small and sleek Pearl will be the simplest-to-operate pump on the market. The Pearl is a fully featured insulin pump addressing the imperatives of safety, reliability, and ease of use required to meet the needs of people with diabetes using intensive insulin therapy."

The Pearl Insulin Pump is designed to simplify diabetes care for the more than 500,000 people worldwide who use an insulin pump and those considering insulin pump therapy. Unlike the insulin pumps currently available, which require users to manually fill an insulin reservoir using a vial of insulin and syringe, the Pearl Insulin Pump uses a 300-unit, pre-filled insulin cartridge that simplifies the process of loading the pump and filling the infusion set by reducing the number of steps required and thereby creating a less time-consuming and more convenient process.

"The Pearl is an important evolution in the design of insulin pumps," said Dr. Anthony D. Andre, Ph.D., CPE, founder of Interface Analysis Associates and current president of the Human Factors and Ergonomics Society, who has performed a number of studies on insulin pumps and other drug delivery systems for diabetes patients. "I believe the Pearl design will reduce errors, safety risks, and user frustrations with key elements of the insulin pump interaction process and create an easy, efficient, and satisfying process for diabetes patients."

This device is not yet available for sale in the United States, pending 510(k) clearance.

About Asante Solutions, Inc.

Based in the heart of Silicon Valley, Asante Solutions, Inc. is a privately-held medical device company developing simple solutions for diabetes. The company, founded in Denmark, was previously known as M2 Medical, Inc. For more information, visit www.asantesolutions.com.


'/>"/>
SOURCE Asante Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedShape Solutions, Inc. Named ATDC Graduate
2. MedShape Solutions, Inc. Announces Breakthrough in ACL Reconstruction
3. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
4. BL Healthcares Next Generation of Wireless Remote Healthcare Solutions, Now on Verizon Wireless 4G LTE Mobile Broadband Network
5. Innovative Clinical Solutions, Ltd. Announces Second and Final Liquidating Cash Distribution
6. MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community
7. D3 Launches New Suite of Solutions, including the First Radiation Oncology Clinical Pathways Program, at the ASTRO Annual Meeting, October 31 - November 3, 2010 in San Diego
8. Sleep Solutions, Inc. Re-incorporates as NovaSom, Inc.
9. MedShape Solutions, Inc. Receives Industry Honors and Awards
10. I3, the Developer of Innovative Infusion Therapy Solutions, to Present at Medtech Insight In3 Conference in Las Vegas, March 4-5, 2010
11. PatientSafe Solutions, Inc. Announces Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... and Strategies - 2016" report to their offering. ... The latest research Autism ... pricing data and benchmarks in the global Autism Spectrum Disorder market. ... What are the key drugs marketed for Autism Spectrum Disorder ...
(Date:2/23/2017)... Limited, ( ASX: ITD ), an innovative diversified healthcare company, is ... December 2016 compared with the previous corresponding period. A full "Results ... . Highlights Profit after ... Earnings per share of 2.2 cents (Dec 2015: 1.2 cents; up ... 11%) Profit before tax of $2.12m (Dec 2015: ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of ... of Pittsburgh points to eight genes that may explain why susceptibility to one of ... results of a study published today in the journal npj Schizophrenia. , “There ...
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of ... Center at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas ... easy access to Highway 121. , As the practice has grown, the need for ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals ... What You See” body image mannequin art competition. Selected from 15 submissions from around ... winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... again hosted their Military Wedding Giveaway, with the winning couple announced on Feb. ... with services generously donated from local vendors: A Matter of Taste, Ryan Rousseau ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
Breaking Medicine News(10 mins):